1.84Open1.85Pre Close36 Volume251 Open Interest71.00Strike Price1.50KTurnover57.98%IV4.87%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.28Extrinsic Value100Contract SizeAmericanOptions Type-0.1587Delta0.0687Gamma247.80Leverage Ratio-0.1712Theta-0.0008Rho-39.33Eff Leverage0.0147Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet